Welcome to our dedicated page for OneMedNet news (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet stock.
OneMedNet Corporation (ONMD) delivers innovative healthcare IT solutions through its iRWD™ platform, specializing in secure medical imaging data exchange. This news hub provides investors and healthcare professionals with essential updates on corporate developments, technological advancements, and strategic partnerships.
Access timely reports on earnings announcements, regulatory milestones, and product innovations that drive OneMedNet's position in medical imaging management. Our curated collection includes press releases detailing new healthcare site integrations, life science collaborations, and platform enhancements.
Key updates cover financial performance metrics, compliance achievements with medical data standards, and expansion of clinical imaging datasets. Stay informed about initiatives combining healthcare technology with progressive financial strategies that shape the company's operational framework.
Bookmark this page for centralized access to OneMedNet's official communications, enabling informed analysis of their role in advancing medical research and secure data exchange solutions. Regularly updated content supports comprehensive tracking of this healthcare IT innovator's market trajectory.
OneMedNet (Nasdaq: ONMD) has announced several important updates. The company has dismissed its former auditors, BF Borgers, after they were banned by the SEC, and appointed WithumSmith+Brown as the new auditing firm.
OneMedNet has regained compliance with Nasdaq's minimum bid price rule, maintaining a stock price of at least $1.00 for ten consecutive business days.
The company has entered into a standby equity purchase agreement with Yorkville Advisors Global, securing up to $25 million in funding.
However, due to the auditor change, OneMedNet has delayed filing its quarterly Form 10-Q, receiving a non-compliance notice from Nasdaq. The company has 60 days to submit a compliance plan.
OneMedNet continues to trade on The Nasdaq Capital Market under the symbol ONMD.
OneMedNet (NASDAQ: ONMD) has entered into a significant data license agreement with a leading U.S.-based global clinical trial design and software company. This partnership will utilize OneMedNet's proprietary iRWD™ platform to securely manage regulatory-grade clinical data, including electronic health records, lab results, and medical imaging. The agreement aims to expand OneMedNet's commercial reach within the global life sciences industry and accelerate the development of new medical therapies. The collaboration is expected to generate a robust funnel of business opportunities through a referral licensing model.
OneMedNet (Nasdaq: ONMD), a leader in regulatory-grade Real World Data (RWD), has joined the Amazon Web Services (AWS) Partner Network (APN) and secured a new client, a computational biotechnology organization, through the AWS Marketplace.
The APN is a global community leveraging AWS programs and resources to build, market, and sell offerings.
OneMedNet President and CEO Aaron Green highlighted the anticipated rapid growth and the advantages of being part of the APN, emphasizing access to comprehensive clinical data via the iRWD™ network.
The new client praised the ease of accessing OneMedNet's curated clinical data through the AWS Marketplace, enhancing their research and development capabilities.
OneMedNet announced a three-year Master Services Agreement with a top-10 global medical technology company, impacting over 150 million patients annually.
The agreement leverages OneMedNet's iRWD™ platform to securely de-identify, search, and curate regulatory-grade clinical data.
This deal highlights growing industry adoption of OneMedNet's platform and aims to enhance the customer's competitive positioning through better-informed decision-making.
OneMedNet announced a significant expansion of its iRWD™ network and platform, boasting a more than five-fold increase.
The company has partnered with new entities, including a nationwide medical records custodian, increasing its network to 1,402 healthcare system and provider partner sites, 31 million patients, and 121.4 million clinical exams.
This growth represents a 472% increase in partner sites, a 170% rise in patients, and a 122% bump in clinical exams since the end of 2023.
CEO Aaron Green emphasized that this expansion aligns with OneMedNet's strategy to leverage real-world data for healthcare innovation.
OneMedNet , a leading curator of precision curated regulatory-grade Real World Data, will participate in the EF Hutton Annual Global Conference on May 15, 2024. The company's President & CEO and Founder & CMO will be presenting at the event, with management holding one-on-one investor meetings.
OneMedNet (Nasdaq: ONMD) has joined ClinEco Inc., a platform that enhances access and distribution for clinical research. This move validates OneMedNet's Real World Data platform within the clinical trial ecosystem. Aaron Green, President and CEO of OneMedNet, expressed excitement at becoming part of this community. ClinEco serves as a networking hub for clinical trial stakeholders, fostering collaboration and innovation in the life sciences sector.